Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Total 13F shares
-
5,850,767
-
Share change
-
-54,332
-
Total reported value
-
$36,215,000
-
Put/Call ratio
-
24%
-
Price per share
-
$6.19
-
Number of holders
-
48
-
Value change
-
-$1,226,692
-
Number of buys
-
25
-
Number of sells
-
29
Institutional Holders of PDS Biotechnology Corp - Common (PDSB) as of Q1 2022
As of 31 Mar 2022,
PDS Biotechnology Corp - Common (PDSB) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,850,767 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA ADVISERS, LP, BlackRock Inc., TWO SIGMA INVESTMENTS, LP, AIGH Capital Management LLC, INSPIRION WEALTH ADVISORS, LLC, FIRST MANHATTAN CO, GEODE CAPITAL MANAGEMENT, LLC, and MARSHALL WACE, LLP.
This page lists
48
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.